1. 2020
  2. High-dose First-line Treatment Regimen for Recurrent Rifampicin-susceptible Tuberculosis. / Decroo, Tom; de Jong, Bouke C; Piubello, Alberto; Souleymane, Mahamadou Bassirou; Lynen, Lutgarde; Van Deun, Armand.

    In: American Journal of Respiratory and Critical Care Medicine, Vol. 201, No. 12, 15.06.2020, p. 1578-1579.

    Research output: Contribution to journalArticle

  3. Tuberculosis treatment: one-shot approach or cascade of regimens : ? / Decroo, Tom; de Jong, Bouke C; Piubello, Alberto; Lynen, Lutgarde; Van Deun, Armand.

    In: Lancet Respiratory Medicine, Vol. 8, No. 2, 2020, p. e4-e5.

    Research output: Contribution to journalLetter

  4. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015. / Makurumidze, Richard; Mutasa-Apollo, Tsitsi; Decroo, Tom; Choto, Regis C; Takarinda, Kudakwashe C; Dzangare, Janet; Lynen, Lutgarde; Van Damme, Wim; Hakim, James; Magure, Tapuwa; Mugurungi, Owen; Rusakaniko, Simbarashe.

    In: PLoS ONE, Vol. 15, No. 1, 2020, p. e0222309.

    Research output: Contribution to journalA1: Web of Science-article

  5. First-line tuberculosis treatment with double-dose rifampicin is well tolerated. / Maug, A K J; Hossain, M A; Gumusboga, M; Decroo, T; Mulders, W; Braet, S; Buyze, J; Arango, D; Schurmans, C; Herssens, N; Demeulenaere, T; Lynen, L; de Jong, B C; Van Deun, A.

    In: International Journal of Tuberculosis and Lung Disease, Vol. 24, No. 5, 2020, p. 499-505.

    Research output: Contribution to journalA1: Web of Science-article

  6. The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance. / Van Deun, Armand; Decroo, Tom; Kya Jai Maug, Aung; Hossain, Mohamed Anwar; Gumusboga, Murid; Mulders, Wim; Ortuño-Gutiérrez, Nimer; Lynen, Lutgarde; de Jong, Bouke C; Rieder, Hans L.

    In: PLoS ONE, Vol. 15, No. 5, 2020, p. e0233500.

    Research output: Contribution to journalA1: Web of Science-article

  7. 2019
  8. Performance of algorithms for tuberculosis active case finding in underserved high-prevalence settings in Cambodia: a cross-sectional study. / Choun, Kimcheng; Decroo, Tom; Mao, Tan Eang; Lorent, Natalie; Gerstel, Lisanne; Creswell, Jacob; Codlin, Andrew J.; Lynen, Lutgarde; Thai, Sopheak.

    In: Global Health Action, Vol. 12, No. 1, 1646024, 2019, p. 1646024.

    Research output: Contribution to journalA1: Web of Science-article

  9. Effect of reliance on Xpert MTB/RIF on time to treatment and multidrug-resistant tuberculosis treatment outcomes in Tanzania: a retrospective cohort study. / Mollel, Edson; Lekule, Isack; Lynen, Lutgarde; Decroo, Tom.

    In: International Health, Vol. 11, No. 6, 2019, p. 520-527.

    Research output: Contribution to journalA1: Web of Science-article

  10. Retention estimates and predictors of attrition following community and facility-based art initiation in Brnue State, Nigeria. / Sagay, H.; Badejo, O.; Oche, J.; Ezeofor, H.; Jwanle, P.; Ochen-Jele, S.; Decroo, T.

    In: Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol. 113, 2019, p. S270-S270.

    Research output: Contribution to journalConference abstract in journal

  11. "I take my pills every day, but then it goes up, goes down. I don't know what's going on": perceptions of HIV virological failure in a rural context in Mozambique. A qualitative research study. / Tarquino, Ivan Alejandro Pulido; Venables, Emilie; Fidelis, Jose Manuel de Amaral; Giuliani, Ruggero; Decroo, Tom.

    In: PLoS ONE, Vol. 14, No. 6, 0218364, 2019, p. e0218364.

    Research output: Contribution to journalA1: Web of Science-article

Previous 1 2 3 Next

ID: 261174